39 Results for "

TYRO3

" in MedChemExpress (MCE) Product Catalog:
Products (39)

39 Results for "TYRO3" in MCE Product Catalog:

72
72 Publications Verification
Referencia número: HY-15150
No. CAS: 1037624-75-1
Pureza:  99.92%
Synonyms: R428; BGB324
Target:  

TAM Receptor

Áreas de investigación:  

Cancer

Bemcentinib (R428) is a selective and orally active Axl inhibitor with an IC50 of 14 nM. Bemcentinib retards cancer cell migration and invasion. Bemcentinib exhibits >100-fold selectivity for Axl versus Abl and 50- and >100-fold selectivity over TAM family kinases Mer and Tyro3, respectively, in cells. Bemcentinib blocks tumor spread and prolongs survival in models of metastatic breast cancer .
loading...
    loading...
13
13 Cited Publications
Referencia número: HY-12076
No. CAS: 1025720-94-8
Pureza:  99.36%
Synonyms: BMS 817378
Target:  

c-Met/HGFR TAM Receptor

Áreas de investigación:  

Cancer

BMS 777607 (BMS 817378) is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50s of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, respectively, and 40-fold more selective for Met-related targets than Lck, VEGFR-2, and TrkA/B, with more than 500-fold greater selectivity versus all other receptor and non receptor kinases .
loading...
    loading...
10
10 Cited Publications
Referencia número: HY-12494
No. CAS: 1361030-48-9
Pureza:  99.64%
Target:  

TAM Receptor FLT3

Áreas de investigación:  

Neurological Disease Cancer

LDC1267 is a AXL/TAM/FLT3 inhibitor with IC50 values of 42 nM, 130 nM, and 63 nM against AXL, MERTK, and TYRO3, respectively. LDC1267 blocks GAS6-induced AXL phosphorylation and the downstream AKT/ERK1/2 signaling pathway. LDC1267 inhibits cancer cell proliferation, colony formation, and glioblastoma cell invasion, without causing obvious impairment of cytotoxic autophagic flux. LDC1267 exerts a synergistic effect when used in combination with Imatinib (HY-15463) in chronic myeloid leukemia models. LDC1267 can be widely applied in studies related to glioblastoma and chronic myeloid leukemia [3].
loading...
    loading...
7
7 Cited Publications
Referencia número: HY-15797
No. CAS: 1493694-70-4
Pureza:  99.92%
Target:  

TAM Receptor

Áreas de investigación:  

Cancer

UNC2250 is a potent and selective Mer inhibitor with an IC50 of 1.7 nM, about 160- and 60-fold selectivity over the closely related kinases Axl/Tyro3.
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-117596
No. CAS: 1350547-65-7
Pureza:  99.92%
Target:  

TAM Receptor

Áreas de investigación:  

Cancer

UNC569 is a potent, reversible, ATP-competitive and orally active Mer kinase inhibitor with an IC50 of 2.9 nM and a Ki of 4.3 nM. UNC569 also inhibits Axl and Tyro3 with IC50s of 37 nM and 48 nM, respectively. UNC569 can be used for acute lymphoblastic leukemia (ALL) and atypical teratoid/rhabdoid tumors research
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-116000
No. CAS: 1642581-63-2
Pureza:  99.94%
Synonyms: Gumarontinib; SCC244
Target:  

c-Met/HGFR

Áreas de investigación:  

Cancer

Glumetinib (SCC244) is a highly selective, orally bioavailable, ATP-competitive c-Met inhibitor with an IC50 of 0.42 nM. Glumetinib has greater than 2400-fold selectivity for c-Met over those 312 kinases evaluated, including the c-Met family member RON and highly homologous kinases Axl, Mer, TyrO3. Antitumor activity .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-117548
No. CAS: 1350549-36-8
Pureza:  98.92%
Áreas de investigación:  

Cardiovascular Disease Cancer

UNC1062 is a highly selective tyrosine kinase (MERTK) inhibitor with an IC50 of 1.1 nM (Morrison Ki = 0.33 nM). UNC1062 exhibits good selectivity for the TAM family (TYRO3 IC50 = 60 nM, AXL IC50 = 85 nM). UNC1062 exhibits significant anti-proliferative effects and induces apoptosis in various cancer models (such as melanoma, gastric cancer, and acute myeloid leukemia). UNC1062 inhibits multiple pathways, including MAPK/ERK, PI3K/AKT and JAK/STAT and affects the motility of head and neck squamous cell carcinoma (HNSCC) cells through the RhoA signaling pathway. UNC1062 inhibits macrophage efferocytosis, and it suitable for research on atherosclerosis [3] .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-125510
No. CAS: 1612782-86-1
Pureza:  99.71%
Target:  

TAM Receptor

Áreas de investigación:  

Neurological Disease Inflammation/Immunology

UNC2541 is a potent and Mer tyrosine kinase (MerTK)-specific inhibitor, binds in the MerTK ATP pocket, with an IC50 of 4.4 nM, more selective over Axl, Tyro3 and Flt3. UNC2541 inhibits phosphorylated MerTK (pMerTK; EC50, 510 nM). UNC2541 abolishes the analgesic and anti-inflammatory effects of ozone in vivo and in vitro [3].
loading...
    loading...
Referencia número: HY-132200
No. CAS: 2226789-82-6
Pureza:  99.93%
Áreas de investigación:  

Cancer

UNC5293 is a MERTK-selective and potent inhibitor (Ki=190 pM). UNC5293 inhibits MERTK (IC50=0.9 nM) and is more selective over Axl, Tyro3 and Flt3. UNC5293 exhibits excellent mouse PK properties and is used for bone marrow leukemia research .
loading...
    loading...
Referencia número: HY-173268
No. CAS: 3051784-94-9
Target:  

TAM Receptor

Áreas de investigación:  

Cardiovascular Disease Cancer

UNC9426 is a potent and selective TYRO3 inhibitor (IC50 = 2.1 nM), demonstrating 276-fold and 90-fold selectivity over MERTK and AXL, respectively. UNC9426 reduces platelet aggregation without increasing bleeding time and blocks TYRO3-dependent functions in tumor cells and macrophages. UNC9426 demonstrates a favorable safety profile with no significant increase in bleeding risk in vivo. UNC9426 can be used for functional studies of TYRO3-dependent phenotypes such as non-small cell lung cancer (NSCLC) .
loading...
    loading...
Referencia número: HY-115719
No. CAS: 2755241-73-5
Pureza:  99.7%
Target:  

Ser/Thr Kinase

Áreas de investigación:  

Neurological Disease

NR162 is a selective CASK (Ca 2+/calmodulin-dependent Ser/Thr kinase) inhibitor with an IC50 of 80 nM and a Kd of 22 nM. NR162 shows about 50-fold selectivity for CASK than TYRO3. NR162 targets the unique GFG motif of CASK and has excellent shape complementarity to the CASK ATP binding pocket. NR162 can be used for the research of neurological diseases .
loading...
    loading...
Referencia número: HY-147218
No. CAS: 2412356-57-9
Pureza:  97.13%
Synonyms: ARRY-067
Target:  

TAM Receptor

Áreas de investigación:  

Cancer

PF-07265807 (ARRY-067) is a kinase inhibitor with primary targets AXL, MERTK, and TYRO3. PF-07265807 acts as an immunomodulator that cross-activates CD8 + T cells by enhancing dendritic cell function. PF-07265807 blocks downstream signal transduction of AXL and MERTK, and inhibits the proliferation and migration of tumor cells with high expression of these two kinases. PF-07265807 is applicable to research related to advanced or metastatic solid tumors, such as colorectal cancer [3].
loading...
    loading...
Referencia número: HY-132893
No. CAS: 2830555-70-7
Target:  

TAM Receptor

Áreas de investigación:  

Neurological Disease Cancer

AZ14145845 is an orally active dual-target type 1½ kinase inhibitor of Mer/Axl, which inhibits Mer kinase (pIC50 = 9.0) and Axl kinase (pIC50 = 7.9) with high selectivity over Flt3 and Tyro3. AZ14145845 suppresses Mer- and Axl-dependent proliferation in Ba/F3 cells and inhibits efferocytosis in macrophages. AZ14145845 reduces the phagocytosis of photoreceptor outer segments by polarized human retinal epithelial cells. AZ14145845 inhibits tumor growth and induces tumor regression in vivo, and its combination with anti-PD1 antibody and ionizing radiation improves the survival rate of mice with colorectal cancer. AZ14145845 causes retinal degeneration in mice, with pathological changes similar to those in MERTK loss-of-function models. AZ14145845 can be used in studies related to retinal degeneration, lymphoma and colorectal cancer .
loading...
    loading...
Referencia número: HY-115778
No. CAS: 2011034-35-6
Target:  

TAM Receptor FLT3

Áreas de investigación:  

Inflammation/Immunology Cancer

UNC3133 is an orally active, limitedly selective MerTK inhibitor with an IC50 of 3.0 nM. UNC3133 inhibits Axl, Tyro3 and Flt3 kinases, with IC50 values of 17 nM, 31 nM and 6.8 nM, respectively. UNC3133 is applicable to the research of inflammatory diseases and cancers .
loading...
    loading...
Referencia número: HY-176205
No. CAS: 3024588-48-2
Synonyms: AB801
Target:  

TAM Receptor

Áreas de investigación:  

Cancer

Ligritinib (AB801) is an orally active AXL receptor tyrosine kinase inhibitor, with a IC50 of 1.8 nM, Ki of 0.024 nM, and Kd of 0.093 nM against human targets. It exhibits broad selectivity against the human kinome, including high selectivity for MERTK and TYRO3. Ligritinib blocks the AXL signaling pathway independent of dimerization inducers, and acts as both a tumor growth inhibitor and an AXL inducer. Ligritinib can be used in research related to clear cell renal cell carcinoma, advanced solid tumors, and non-small cell lung cancer .
loading...
    loading...
Referencia número: HY-124502
No. CAS: 1818234-19-3
Pureza:  99.80%
Target:  

TAM Receptor FLT3

Áreas de investigación:  

Cancer

UNC4203 is a potent, orally available and highly selective MERTK inhibitor, with IC50s of 1.2 nM, 140 nM, 42 nM and 90 nM for MERTK, AXL, TYRO3 and FLT3, respectively .
loading...
    loading...
Referencia número: HY-RS15308
Áreas de investigación:  

Others

TYRO3 Human Pre-designed siRNA Set A contains three designed siRNAs for TYRO3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Referencia número: HY-RS17427
Áreas de investigación:  

Others

Tyro3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Tyro3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Referencia número: HY-RS23882
Áreas de investigación:  

Others

Tyro3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tyro3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Referencia número: HY-172796
No. CAS: 3091640-25-1
Áreas de investigación:  

Cancer

UNC9435 is a TYRO3/MERTK receptor tyrosine kinase inhibitor with IC50 values of 3.7 nM and 1.1 nM, respectively. UNC9435 inhibits TYRO3/MERTK kinase activity and autophosphorylation. UNC9435 shows certain inhibitory activity against AXL, LCK, PDGFRα, and TRKA. UNC9435 inhibits PROS1 (HY-P74614)-stimulated downstream AKT signaling, macrophage efferocytosis, and colony formation. UNC9435 can be used in research related to non-small cell lung cancer .
loading...
    loading...